The Easy Money’s Been Made
Research - Our goal was to roll profit from this short-term trade into a small, longer-term position in SRNE, which we plan to let ride through TRIBECA.
PremiumThe early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumResearch - Our goal was to roll profit from this short-term trade into a small, longer-term position in SRNE, which we plan to let ride through TRIBECA.
PremiumRecap - Merry Christmas and Happy Holidays! Wishing you and yours a spectacular 2015! We were one and one in last week’s healthcare recap. The v-bottom played out as many expected, … Continue Reading
Read nowResearch - Achillion Pharmaceuticals (ACHN) reported anticipated data for its nucleotide inhibitor ACH-3422 this morning alongside data from a phase 2 proxy study.
PremiumRecap - We’re in the throes of yet another sharp “V-bottom” for the S&P 500 (SPX), a rapid drop followed by a rip-your-face off rally – the 10th occurrence … Continue Reading
Read nowResearch - On Monday, Sorrento announced that Dr. Patrick Soon-Shiong made a $41 million investment in the company and now owns 19.9% of Sorrento.
PremiumInsights - Agenus (AGEN) announced on Thursday that a shingles vaccine being developed by GlaxoSmithKline (GSK), and using a proprietary adjuvant licensed from AGEN, was succesful in … Continue Reading
Read nowInsights - Investor/entrepreneur Dr. Patrick Soon-Shiong is making a sizable investment in Sorrento Therapeutics (SRNE), in addition to forming a joint venture with the small company to develop … Continue Reading
Read now